Position in COGT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$174,498,222
+$32,103,737 QoQ
Shares Held
4,508,998
+21.9% QoQ
Ownership
2.60%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#11
of 321 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. COGT ranks #32 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in COGT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $174,498,222 | 4,508,998 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $142,394,485 | 3,699,519 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $124,837,241 | 3,514,562 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $47,016,864 | 3,274,155 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $19,185,770 | 2,672,113 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $14,470,964 | 2,415,854 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $18,006,369 | 2,308,509 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $24,632,564 | 2,280,793 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $16,697,561 | 1,980,731 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $11,942,138 | 1,777,104 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $10,165,238 | 1,728,782 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $16,060,648 | 1,647,246 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $17,881,880 | 1,510,294 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $14,224,543 | 1,318,308 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,130,134 | 1,222,330 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $17,527,419 | 1,174,760 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,656,074 | 737,924 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,468,998 | 596,662 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,962,406 | 578,369 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,858,995 | 577,764 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,654,077 | 573,869 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,169,046 | 247,044 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,384,735 | 212,354 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 UMRX | — | 98,621 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 UMRX | — | 73,454 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 UMRX | — | 73,454 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||